Nordic Bioscience is running a booth at EULAR '22
The European Congress of Rheumatology 2022 (EULAR 2022 Congress) is an important step in rebuilding the personal connections that help advance science. It is a great opportunity to meet again in person and co-produce value in the latest research and inventions for patients suffering from rheumatic diseases. This year Nordic Bioscience is running a booth at EULAR 2022 in Copenhagen.
"The aim of the European Congress of Rheumatology is to provide a forum of the highest standard for scientific (both clinical and basic), educational and social exchange between professionals involved in rheumatology, liaising with patient organisations, in order to achieve progress in the clinical care of people with rheumatic diseases." (EULAR 2022)
For the first time, Nordic Bioscience will have a booth where you can meet our Rheumatology team to learn more about how our blood-based biomarkers can support your translational and clinical research.
Our business developers will be on hand to ensure you do not miss out on the potential for future collaboration for the benefit of patients, and that you leave with actionable insights.
Our booth is open to anyone from academia or business who is interested in learning more about how we advance science and medicine. We welcome students and executives alike to a collaborative environment and serve coffee to facilitate interesting discussions.
We are also giving out a limited number of useful items. So stop by our booth early before they are gone!
Finally, our scientific team will present some of our latest data in rheumatology at EULAR 2022:
- 01 June, 08:32-08:40, Oral Session - Biomarkers of inflammation and joint tissue turnover can help improve the differentiation between osteoarthritis and psoriatic arthritis patients (Solveig Skovlund Groen)
- 01 June, 17:45-17:55 - Serological collagen biomarkers can differentiate patients with psoriasis from psoriatic arthritis (Solveig Skovlund Groen)
- 02 June, 12:42-12:50 - Identification of Fibrotic and Fibrolytic Endotypes in Rheumatic Disease Cohorts (Dr. Anne-Christine Bay-Jensen)
See you in Copenhagen!
Team Nordic
Set up a meeting with us
